Postmarket Safety

GOP Lawmakers Float Prescription Drug Abuse Bill

New GOP-proposed legislation aimed at curbing prescription drug abuse would require certain generic drugmakers to conduct background checks and perform drug testing for employees with access to controlled substances. Read More

Sun Pharma, Ranbaxy Face U.S. Recalls

Indian generics makers Sun Pharma and Ranbaxy are both facing individual Class II U.S. recalls related to product mixups. Both recalls were included in the FDA’s March 5 enforcement report. Read More